Login
| TI Ref No : | 527224252 |
|---|---|
| Description : | Contract Awarded For Ta2026 -lot 155 Risankizumab - Skyrizi - Derived From Am 27/2022 Of Exclusive Medicines From Sermas - Milestone 1 - Hcd award Amount: 48076.92 Euros.ta2026 -lot 155 Risankizumab - Skyrizi - Derived From Am 27/2022 Of Exclusive Medicin |
| Date : | 2026-01-06 |
| Deadline : | 2026-04-02 |
| Document Type : | Contracts |
